Search results for "Metas"

showing 10 items of 1693 documents

The Epithelial Mesenchymal Transition Process in Wilms Tumor

2011

Background Until now, only a few mouse-transplanted human tumors or experimental Wilms tumor (WT) cell lines have been described. The aim of this study was to show the biological behavior, including histology, immunohistochemistry (IHC), and molecular biology, of a WT including the original tumor and metastasis transferred into nude mice and followed for successive generations in xenografts. Methods A WT metastasis was xenotransplanted into nude mice and the mice was monitored for 7 passages over a period of 29 months; the original neoplasm was comparatively studied. The morphology was evaluated by optical and electron microscopy. The protein expression was analyzed by immunohistochemistry …

Epithelial-Mesenchymal TransitionHistologyDNA Mutational AnalysisMice NudeCell Growth ProcessesWilms TumorBone and BonesPathology and Forensic MedicineMetastasisMicemedicineAnimalsHumansEpithelial–mesenchymal transitionNeoplasm MetastasisOncogene ProteinsN-Myc Proto-Oncogene ProteinTissue microarrayChemistryMesenchymal stem cellNuclear ProteinsEye Diseases HereditaryWilms' tumorHistologyStriated muscle cell differentiationMicroarray Analysismedicine.diseaseImmunohistochemistryXenograft Model Antitumor AssaysKidney NeoplasmsWnt ProteinsRadiusMedical Laboratory TechnologyMutationCancer researchImmunohistochemistrySignal TransductionApplied Immunohistochemistry & Molecular Morphology
researchProduct

Potential Anti-Metastatic Role of the Novel miR-CT3 in Tumor Angiogenesis and Osteosarcoma Invasion

2022

Osteosarcoma (OS) is the most common primary bone tumor mainly occurring in young adults and derived from primitive bone-forming mesenchyme. OS develops in an intricate tumor microenvironment (TME) where cellular function regulated by microRNAs (miRNAs) may affect communication between OS cells and the surrounding TME. Therefore, miRNAs are considered potential therapeutic targets in cancer and one of the goals of research is to accurately define a specific signature of a miRNAs, which could reflect the phenotype of a particular tumor, such as OS. Through NGS approach, we previously found a specific molecular profile of miRNAs in OS and discovered 8 novel miRNAs. Among these, we deepen our …

Epithelial-Mesenchymal TransitionQH301-705.5MAP Kinase Signaling SystemEMT proteinBone NeoplasmsArticleCatalysisCell LineInorganic ChemistryCell Line TumorHuman Umbilical Vein Endothelial CellsmetastasisHumansNeoplasm InvasivenessBiology (General)Physical and Theoretical ChemistryQD1-999Molecular BiologySpectroscopyOsteosarcomaOsteoblastsmicroRNANeovascularization PathologicOrganic ChemistryEMT proteinstumor angiogenesisGeneral MedicinemicroRNAsComputer Science ApplicationsGene Expression Regulation NeoplasticChemistryosteosarcoma; microRNAs; tumor angiogenesis; metastasis; EMT proteinsmetastasitumor angiogenesiInternational Journal of Molecular Sciences
researchProduct

Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer

2015

Metastasis is the main cause of cancer mortality. One of the initiating events of cancer metastasis of epithelial tumors is epithelial-to-mesenchymal transition (EMT), during which cells dedifferentiate from a relatively rigid cell structure/morphology to a flexible and changeable structure/morphology often associated with mesenchymal cells. The presence of EMT in human epithelial tumors is reflected by the increased expression of genes and levels of proteins that are preferentially present in mesenchymal cells. The combined presence of these genes forms the basis of mesenchymal gene signatures, which are the foundation for classifying a mesenchymal subtype of tumors. Indeed, tumor classifi…

Epithelial-Mesenchymal TransitionReviewBiologyBioinformaticsMetastasis03 medical and health sciences0302 clinical medicinemicroRNAGene expressionmedicineHumanscancerEpithelial–mesenchymal transitionCystadenocarcinomaGene030304 developmental biologyOvarian Neoplasms0303 health sciencesMessenger RNAmiR-506Mesenchymal stem cellmiR-101medicine.diseaseCystadenocarcinoma Serous3. Good healthMicroRNAsOncology030220 oncology & carcinogenesisCancer researchFemaleovaryMicroRNA (miRNA)epithelial-to-mesenchymal transition (EMT)Chinese Journal of Cancer
researchProduct

Multicenter study of the eValuation of Eribulin (E) use in Sicily in metastatic breast cancer (MBC): A Prospective RegistrY (VESPRY trial)

2015

e12565 Background: Eribulin Mesylate is a non taxane microtubule dynamics inhibitor, approved for heavily-pretreated MBC patients (pts). Methods: This is a multicenter, prospective, single arm study for E-treatment of third line in pretreated MBC pts, conducted in 14 oncology centers in Sicily. All pts had received two previous chemotherapy regimens for MBC. Pts received E at 1.23 mg/m2 on days 1,8 every 3 weeks until progression. Primary Endpoints: overall response rate (ORR) according to the site of metastases and safety. Secondary objectives: Progression-free survival (PFS) and ORR according to different subtypes. PFS curve was estimated using the Kaplan-Meier method. Multivariable logi…

Eribulin MesylateGynecologyOncologyCancer Researchmedicine.medical_specialtyTaxaneMicrotubule dynamicsbusiness.industryHematologymedicine.diseaseMetastatic breast cancerSurgerychemistry.chemical_compoundOncologychemistryInternal medicineMedicinebusinessEribulinAnnals of Oncology
researchProduct

Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Ef…

2021

Objective Eribulin mesylate (EM) is a fully synthetic macrocyclic ketone analogue of the marine natural product halichondrin. EM has been reported to be active in metastatic breast cancer. In this paper, we report efficacy and safety of data of EM in a retrospective, real-world series of patients with poor prognosis, hormone-refractory, or triple-negative metastatic breast cancer. Materials and methods The analysis was carried out at 4 interrelated oncology centers. EM was delivered at the dose of 1.4 mg/m2 in 100 mL of normal saline over 2 to 5 minutes on days 1 and 8 every 21 days. EM was continued until disease progression or unacceptable toxicity. Side effects were reported every cycle …

Eribulin MesylateOncologyAdultCancer Researchmedicine.medical_specialtyNeoplasms Hormone-Dependenteribulin mesylateSettore MED/06 - Oncologia Medicamedicine.medical_treatmentAntineoplastic AgentsTriple Negative Breast Neoplasmstriple negative03 medical and health sciences0302 clinical medicineStable DiseaseBreast cancerbreast cancerInternal medicineAntineoplastic Combined Chemotherapy Protocolshormonal refractorymedicineHumans030212 general & internal medicineFuransSalineTriple-negative breast cancerAgedRetrospective StudiesChemotherapybusiness.industryKetonesMiddle Agedmedicine.diseaseMetastatic breast cancerSettore MED/18 - Chirurgia GeneraleTreatment OutcomeOncology030220 oncology & carcinogenesisToxicityFemalebusiness
researchProduct

A highly dynamic hot hydrothermal system in the subduction environment: Geochemistry and geochronology of jadeitite and associated rocks of the Sierr…

2021

A U-Pb zircon date of ~113 Ma revealed that a variety of jadeitites and related omphacitite, chloritite and albite-rich rocks from the subduction-related Sierra del Convento block-in-serpentinite-matrix mélange (eastern Cuba) formed nearly synchronously with MORB metabasite-derived anatectic trondhjemitic liquids at high-temperature and pressure in a hot subduction environment. Field, petrologic and geochemical data indicate hydrothermal/metasomatic processes triggered by juvenile fluids likely evolved from the crystallizing hydrous trondhjemitic melts. These fluids, variably mixed with sediment-derived fluids and channelized along fractures in the supra-slab mantle, precipitated relatively…

European communitySubductionSerpentinite mélangeSubductionArchaeologyHydrothermal circulationRocas metamóficasMetasomatic transformationGeochronologySerpentinite melangeGeneral Earth and Planetary SciencesJadeititeFluid-rock interactionGeologyPetrología y GeoquímicaAmerican Journal of Science
researchProduct

AGO Algorithms for the Treatment of Breast Cancer: Update 2021

2021

Geburtshilfe und Frauenheilkunde 81(10), 1101-1111 (2021). doi:10.1055/a-1519-7089

Evidence-based practicePerformance statusbusiness.industryObstetrics and GynecologyTreatment optionsRecommendationmedicine.diseasetherapy algorithmsPatient preferenceMetastatic breast cancerevidence-based treatmentBreast cancerevidenzbasierte TherapieMaternity and Midwiferybreast cancer guidelinesmedicineTreatment decision makingGebFra ScienceBehandlungsalgorithmenbusinessAlgorithmBrustkrebs-Leitlinien
researchProduct

Breakthrough Pain (BTP) in Opioid-Tolerant Cancer Patients: A Pan-European Open-Label Multicentre Study with Fentanyl Buccal Tablet (FBT)

2012

ABSTRACT BTP, a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain, is a common problem in cancer patients. FBT is indicated for the treatment of BTP in adults with cancer already receiving maintenance opioid therapy for chronic cancer pain and should be titrated to an effective dose that provides adequate analgesia and minimises undesirable events. In this study, patients entered a screening period and were randomized during an open-label titration period to a starting FBT dose of 100 µg (group A) or 200 µg (group B) to identify the FBT effective dose and then treated in an open-label period (for 8 BTP episodes). Patients' inclusion followed…

Exacerbationbusiness.industryBreakthrough PainRectumBone metastasisHematologymedicine.diseaseEffective dose (pharmacology)Group Bmedicine.anatomical_structureOncologyOpioidAnesthesiaFentanyl Buccal Tabletmedicinebusinessmedicine.drugAnnals of Oncology
researchProduct

Resonances in the electron impact excitation of metastable states of mercury

1984

Metastable excitation of mercury by electron impact is studied at energies up to the first ionisation potential using an energy selected electron beam with an energy spread of 50 meV FWHM. A great number of resonances is observed in the excitation function. Agreement is good on the whole with a recent relativisticR-matrix calculation and with a former analysis of resonances in the elastic cross section.

Excitation functionElastic scatteringPhysicsNuclear and High Energy PhysicsMetastabilityIonizationCathode rayNuclear fusionAtomic physicsExcitationElectron ionizationZeitschrift f�r Physik A Atoms and Nuclei
researchProduct

A systematic review on external ear melanoma

2014

Summary Background External ear melanoma accounts for only 1% of all cutaneous melanomas, and data on its optimal management and prognosis are limited. Aim We aim to review the literature on external ear melanoma to guide surgeons in the treatment of this uncommon and peculiar pathology. Materials and methods A systematic review of English language studies on ear melanoma published from 1993 to 2013 was performed using the PubMed electronic database. Data on epidemiology, oncological treatment (tumor resection and regional lymph nodes management), and reconstruction were extrapolated from selected papers. Results The total number of patients was 858 (30 studies). The helix was the most comm…

External earmedicine.medical_specialtySkin NeoplasmsPrognosiSentinel lymph nodeSettore MED/19 - Chirurgia PlasticaSurgical FlapsBreslow ThicknessEpidemiologyBiopsymedicineHumansReconstructive Surgical ProcedureSkin NeoplasmStage (cooking)Ear ExternalMelanomaEar NeoplasmsNeoplasm Stagingmedicine.diagnostic_testbusiness.industrySentinel Lymph Node BiopsyMelanomaLymphatic MetastasiPlastic Surgery Proceduresmedicine.diseasePrognosisOptimal managementSuperficial spreading melanomaSurgeryEar NeoplasmSurgical FlapLymphatic MetastasisSurgeryNeoplasm Recurrence LocalbusinessEar melanomaMelanoma treatmentHuman
researchProduct